“B cell lymphomas”的搜索结果，显示 131-140 项，共有 7765 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and tolerability of STP938 as a single agent in adult subjects with R/R B-cell and T-cell lymphomas.

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

4. 血液科- 临床试验- 妙佑医疗国际

   ... B cell lymphoma (DLBCL) after receiving at least two lines of therapy. Additional cohorts include subjects with B-cell primary or secondary central nervous ...

5. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...

6. 淋巴瘤- 医生与科室- 妙佑医疗国际

   in lymphoma, Chronic lymphocytic leukemia, Small lymphocytic lymphoma, B-cell lymphoma, Hairy cell leukemia, Burkitt lymphoma, Follicular lymphoma. 显示更多 ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... B-cell Lymphoma (R/R DLBCL). Rochester, Minn. Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...

9. 皮肤 B 细胞淋巴瘤- 诊断与治疗- 妙佑医疗国际

   Vitiello P, et al. Primary cutaneous B-cell lymphomas: An update. Frontiers in Oncology. 2020; doi:10.3389/fonc.2020.00651. Cancer staging. National Cancer ...

10. 血液科- 临床试验- 妙佑医疗国际

    Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...